Want to see SE:EXPRS2 full AI Analyst Report?
ExpreS2ion Biotech Holding AB (EXPRS2) Income Statement
ExpreS2ion Biotech Holding AB Income Statement
Last quarter (Q2 2026), ExpreS2ion Biotech Holding AB's total revenue was $2.01M, an increase of 30.84% from the same quarter last year. In Q2, ExpreS2ion Biotech Holding AB's net income was $-9.70M. See ExpreS2ion Biotech Holding AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.66M | $ 3.01M | $ 7.05M | $ 5.09M | $ 12.23M | |
| $ -42.84M | $ -2.67M | $ 3.40M | $ 5.00K | $ 4.72M | |
| $ 9.98M | $ 69.84M | $ 111.12M | $ 127.61M | $ 53.12M | |
| Depreciation and Amortization | $ 1.47M | $ 1.64M | $ 1.60M | $ 1.22M | $ 1.81M |
| $ -51.35M | $ -64.34M | $ -102.45M | $ -124.49M | $ -46.38M | |
| $ -52.82M | $ -67.69M | $ -105.97M | $ -127.61M | $ -48.40M | |
| $ 8.64M | $ 23.13M | $ 6.00M | $ 1.02M | $ 880.00K | |
| $ -44.18M | $ -44.56M | $ -99.97M | $ -126.58M | $ -47.52M | |
| $ -38.09M | $ -36.04M | $ -91.40M | $ -118.61M | $ -43.92M | |
| Per Share Metrics | |||||
| Basic EPS | $ -13.39 | $ -21.31 | $ -79.20 | $ -125.60 | $ -54.40 |
| Diluted EPS | $ -13.39 | $ -14.02 | $ -79.20 | $ -125.60 | $ -54.40 |
| Weighted Average Shares Outstanding | 2.84M | 1.69M | 1.15M | 943.47K | 806.21K |
| Weighted Average Shares Outstanding (Diluted) | 2.84M | 2.60M | 1.15M | 943.47K | 806.21K |
Currency in SEK